HK1056998A1 - Pharmaceutical composition comprising condensed indole compound - Google Patents
Pharmaceutical composition comprising condensed indole compoundInfo
- Publication number
- HK1056998A1 HK1056998A1 HK03107575A HK03107575A HK1056998A1 HK 1056998 A1 HK1056998 A1 HK 1056998A1 HK 03107575 A HK03107575 A HK 03107575A HK 03107575 A HK03107575 A HK 03107575A HK 1056998 A1 HK1056998 A1 HK 1056998A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- indole compound
- salt
- condensed indole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0019524A GB0019524D0 (en) | 2000-08-08 | 2000-08-08 | Novel use |
GB0118919A GB0118919D0 (en) | 2001-08-02 | 2001-08-02 | Novel use |
GB0119022A GB0119022D0 (en) | 2001-08-03 | 2001-08-03 | Novel use |
PCT/GB2001/003544 WO2002011766A2 (en) | 2000-08-07 | 2001-08-07 | Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
PCT/GB2001/003590 WO2002011733A1 (en) | 2000-08-08 | 2001-08-08 | Pharmaceutical composition comprising condensed indole compound |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1056998A1 true HK1056998A1 (en) | 2004-03-12 |
Family
ID=27255838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03107575A HK1056998A1 (en) | 2000-08-08 | 2003-10-17 | Pharmaceutical composition comprising condensed indole compound |
Country Status (12)
Country | Link |
---|---|
US (3) | US20030032640A1 (pt) |
EP (2) | EP1872785A1 (pt) |
JP (1) | JP2008247915A (pt) |
KR (1) | KR100896563B1 (pt) |
CN (2) | CN1679583A (pt) |
AT (1) | ATE374027T1 (pt) |
BR (1) | BR0113169A (pt) |
CY (1) | CY1107836T1 (pt) |
HK (1) | HK1056998A1 (pt) |
MX (1) | MXPA03001207A (pt) |
NZ (1) | NZ535261A (pt) |
PT (1) | PT1313481E (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL365048A1 (en) * | 2000-08-07 | 2004-12-27 | Laboratoire Glaxosmithkline S.A.S. | Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
DK1476136T3 (da) * | 2002-02-14 | 2006-10-09 | Glaxo Group Ltd | Farmaceutisk præparat, der omfatter N-[(1-N-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indol-10-carboxamid eller salt, og fremgangsmåde derfor, der omfatter törgranulering |
GB0211230D0 (en) * | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
EP2397161B1 (en) * | 2009-02-12 | 2019-09-25 | Fuji Chemical Industry Co., Ltd. | Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same |
TW201129386A (en) * | 2009-11-05 | 2011-09-01 | Fmc Corp | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |
WO2014200347A1 (en) * | 2013-06-14 | 2014-12-18 | Ferring B.V. | Extended release nicotinamide formulation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3134719A (en) * | 1962-04-05 | 1964-05-26 | American Cyanamid Co | Calcium phosphates in tablet compressing |
US5066441A (en) * | 1980-12-12 | 1991-11-19 | Rhone-Poulenc Basic Chemicals Co. | Process for compacting a calcium phosphate composition |
US4597969A (en) * | 1982-04-05 | 1986-07-01 | Merck Sharp & Dohme | Stabilization of unstable drugs or food supplements |
DE3332830A1 (de) * | 1982-09-16 | 1984-03-22 | The Upjohn Co., 49001 Kalamazoo, Mich. | Verwendung von benzodiazepinen zur bekaempfung oder bei der behandlung von panikzustaenden |
US4569852A (en) * | 1983-08-23 | 1986-02-11 | Warner-Lambert Company | Maintenance of flavor intensity in pressed tablets |
US4713245A (en) * | 1984-06-04 | 1987-12-15 | Mitsui Toatsu Chemicals, Incorporated | Granule containing physiologically-active substance, method for preparing same and use thereof |
US5055307A (en) * | 1988-12-29 | 1991-10-08 | Asahi Kagaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
ES2132223T3 (es) * | 1992-03-12 | 1999-08-16 | Smithkline Beecham Plc | Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4. |
US5998409A (en) * | 1992-03-12 | 1999-12-07 | Smithkline Beecham Plc | Condensed indole derivatives as 5HT4 -receptor antagonists |
DE4418837A1 (de) * | 1994-05-30 | 1995-12-07 | Bayer Ag | Thermisches Granulierverfahren |
FR2740357B1 (fr) * | 1995-10-25 | 1997-11-28 | Rhone Poulenc Chimie | Granules redispersables dans l'eau comprenant une matiere active sous forme liquide et un tensio-actif non ionique du type alcoxyles |
GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
US6660298B1 (en) * | 2000-07-27 | 2003-12-09 | Pentech Pharmaceuticals, Inc. | Paroxetine tablets and capsules |
-
2001
- 2001-08-07 NZ NZ535261A patent/NZ535261A/xx unknown
- 2001-08-08 AT AT01954214T patent/ATE374027T1/de active
- 2001-08-08 BR BR0113169-9A patent/BR0113169A/pt not_active Application Discontinuation
- 2001-08-08 KR KR1020037001875A patent/KR100896563B1/ko not_active IP Right Cessation
- 2001-08-08 EP EP07116828A patent/EP1872785A1/en not_active Withdrawn
- 2001-08-08 EP EP07117093A patent/EP1867333A1/en not_active Withdrawn
- 2001-08-08 PT PT01954214T patent/PT1313481E/pt unknown
- 2001-08-08 CN CNA200510068902XA patent/CN1679583A/zh active Pending
- 2001-08-08 CN CNB018158404A patent/CN1268340C/zh not_active Expired - Fee Related
- 2001-08-08 MX MXPA03001207A patent/MXPA03001207A/es active IP Right Grant
-
2002
- 2002-01-23 US US10/055,817 patent/US20030032640A1/en not_active Abandoned
-
2003
- 2003-10-17 HK HK03107575A patent/HK1056998A1/xx not_active IP Right Cessation
-
2005
- 2005-02-10 US US11/054,837 patent/US20050148582A1/en not_active Abandoned
- 2005-08-09 US US11/203,573 patent/US20060057218A1/en not_active Abandoned
-
2007
- 2007-12-18 CY CY20071101602T patent/CY1107836T1/el unknown
-
2008
- 2008-04-23 JP JP2008112982A patent/JP2008247915A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20060057218A1 (en) | 2006-03-16 |
ATE374027T1 (de) | 2007-10-15 |
CN1268340C (zh) | 2006-08-09 |
MXPA03001207A (es) | 2004-08-12 |
BR0113169A (pt) | 2003-07-15 |
NZ535261A (en) | 2004-12-24 |
PT1313481E (pt) | 2008-01-02 |
US20030032640A1 (en) | 2003-02-13 |
KR100896563B1 (ko) | 2009-05-07 |
US20050148582A1 (en) | 2005-07-07 |
EP1867333A1 (en) | 2007-12-19 |
EP1872785A1 (en) | 2008-01-02 |
CY1107836T1 (el) | 2013-06-19 |
CN1679583A (zh) | 2005-10-12 |
CN1458845A (zh) | 2003-11-26 |
JP2008247915A (ja) | 2008-10-16 |
KR20030023745A (ko) | 2003-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107836T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενωση συμπυκνωμενης ινδολης | |
CA2427815A1 (en) | Controlled release hydrocodone formulations | |
EP0904781A3 (en) | Improved pharmaceutical composition comprising fenofibrate | |
HUP9601884A3 (en) | 6-(dimethylamino-methyl)-1-phenyl-cyclohexane compounds, their use as pharmaceutically active analgetic matarials and process for their preparation | |
WO2001042219A3 (en) | Novel substituted phenanthridinones and methods of use thereof | |
LU91563I2 (fr) | Combinaisson comprenant de l'aliskiren, comme baselibre ou comme un de ses sels pharmaceutiquement acceptables, et de l'hydrochlorothiazide ou un de ses sels pharmaceutiquement acceptables-Rasilez HCT | |
UA66952C2 (uk) | N-(5,7-диметокси[1,2,4]триазоло[1,5-a]піримідин-2-іл)арилсульфонамід, спосіб його одержання, композиція на його основі та спосіб боротьби з небажаною рослинністю | |
BG103881A (en) | Method for the preparation of elurbiprophene pastills | |
MY130208A (en) | Quetiapine granules | |
MXPA03009527A (es) | PROCEDIMIENTO PARA LA PREPARACIoN DE INDENOS 1,3-SUSTITUIDOS Y COMPUESTOS AZAPOLICICLICOS CONDENSADOS CON ARILO. | |
AP9801423A0 (en) | 2,3-substituted indole compounds as anti-inflammatory and analgesic agents | |
HUP0001313A3 (en) | Process for the crystallization of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one | |
WO2003045328A3 (en) | Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof | |
WO2000058307A3 (en) | Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands | |
HUP0303487A3 (en) | Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anthiarhythmic agents and process for preparation of the compounds | |
CA2335328A1 (en) | A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom | |
NO991194D0 (no) | Kontrollert-frigj°ring doseform av [R-(Z)-<alfa>-(metoksyimino)-<alfa>-(azabisyklo[2,2,2]okt-3-yl)acetonitril monohydroklorid | |
AU4316301A (en) | Novel 2,3,4,5-tetrahydro-1H-(1,4)diazepino(1,7a)indole compounds | |
AU1054500A (en) | N-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives, their preparation and their use as selective mglur1 antagonists | |
EE200000619A (et) | Oktahüdro-6,10-diokso-6H-püridasino[1,2-a][1,2]diasepiin-1-karboksüülhappe derivaadid, nende ratseemiline segu, valmistamismeetod ja kasutamine ning vaheühendid | |
HUP9900883A3 (en) | Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists | |
IL130368A0 (en) | Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds | |
CA2264549A1 (en) | Spirocyclic dopamine receptor subtype ligands | |
HUP0204111A3 (en) | Novel process for the preparation of alpha-(2,4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof | |
AU6003099A (en) | Fused pyridazine compounds, process for the preparation of the same and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110808 |